Buspirone for management of dyspnea in cancer patients receiving chemotherapy: a randomized placebo-controlled URCC CCOP study
Anita R. Peoples(University of Utah), Gary R. Morrow(University of Rochester Medical Center), Judith O. Hopkins(Novant Health), Charles E. Heckler(University of Rochester Medicine), Deborah Dudgeon(Cancer Care Ontario), Joseph A. Roscoe(University of Rochester), Shaker R. Dakhil(Cancer Center of Kansas), Luke L. Peppone(University of Rochester Medicine), Peter Bushunow(Rochester General Hospital), Tarit K. Banerjee(Marshfield Clinic), Sheila N. Garland(Memorial University of Newfoundland), Jeffrey J. Kirshner(American Society of Clinical Oncology), Marie Flannery(National Cancer Research Institute)
Cited by 38
Related Papers
Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue
|JAMA Oncology|2017|913
Postmastectomy Radiotherapy: Clinical Practice Guidelines of the American Society of Clinical Oncology*
|Journal of Clinical Oncology|2001|819
Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines
|Journal of Clinical Oncology|1999|670
Prevalence, Demographics, and Psychological Associations of Sleep Disruption in Patients With Cancer: University of Rochester Cancer Center–Community Clinical Oncology Program
|Journal of Clinical Oncology|2009|564
Impact of mindfulness-based stress reduction (MBSR) on sleep, mood, stress and fatigue symptoms in cancer outpatients
|International Journal of Behavioral Medicine|2005|556